跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
YUPELRI 175 mcg / 3 ml - SFDA Drug Approval Details
Approvals
/
SFDA
/
YUPELRI 175 mcg / 3 ml
Authorized
NCE
YUPELRI 175 mcg / 3 ml
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
84c561c6a40cfa92
Company
Unknown
Type
NCE
Approval Details
Approval Id
84c561c6a40cfa92
Drug Approval Sfda Name
YUPELRI 175 mcg / 3 ml
Trade Name
YUPELRI 175 mcg / 3 ml
Generic Name
REVEFENACIN
Register Number
0908222440
Register Year
2022
Drug Type
NCE
Route Of Administration
Inhalation use
Package Type
Single Dose Container
Package Size
7
Size
3
Size Unit
ml
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
store below 30°c
Shelf Life
36 Months
Distribution Site
Pharmacy
Description Code
7000002311-175-100000074070
Price
71.5
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
84c561c6a40cfa92
Type
NCE
Back to SFDA Approvals